{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:23:50Z","timestamp":1793071430851,"version":"4.5.0"},"reference-count":75,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Colorectal cancer (CRC) accounted for nearly 2 million new cases and over 900,000 deaths worldwide in 2020. Current treatment strategies include surgery, chemotherapy, radiotherapy, and targeted therapies, including monoclonal antibodies and other forms of immunotherapy. Despite these options, high mortality rates and frequent treatment-related adverse effects underscore the urgent need for novel therapeutic approaches. Epigallocatechin-3-gallate (EGCG), the most abundant catechin in green tea, exhibits potent antioxidant, anti-inflammatory, and anticancer activities. This review summarizes evidence from the past decade on the in vitro and in vivo effects of EGCG in CRC. In vitro studies demonstrate that EGCG inhibits cell proliferation and migration while inducing apoptosis through multiple molecular mechanisms, including modulation of signaling pathways such as Wnt\/\u03b2-catenin, PI3K\/Akt, and NF-\u03baB. In vivo studies in mouse xenograft models indicate that EGCG reduces tumor growth, volume, and mass. Nevertheless, additional in vivo investigations are needed to fully define EGCG\u2019s therapeutic potential and its translational relevance for human clinical trials.<\/jats:p>","DOI":"10.3390\/cancers18152391","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T13:53:26Z","timestamp":1784901206000},"page":"2391","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Epigallocatechin-3-Gallate (EGCG) as a Multifaceted Natural Anticancer Agent in Colorectal Cancer: Preclinical Evidence and Future Directions"],"prefix":"10.3390","volume":"18","author":[{"given":"Nicolaos","family":"Achilleos","sequence":"first","affiliation":[{"name":"Department of Health Sciences, Faculty of Applied Health Sciences, Brock University, St. Catharines, ON L2S 3A1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddox Talbot","family":"Harrison","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Faculty of Applied Health Sciences, Brock University, St. Catharines, ON L2S 3A1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4218-5851","authenticated-orcid":false,"given":"Evangelia","family":"Tsiani","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Faculty of Applied Health Sciences, Brock University, St. Catharines, ON L2S 3A1, Canada"},{"name":"Centre for Bone and Muscle Health, Applied Health Sciences, Brock University, St. Catharines, ON L2S 3A1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"ref_1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"101174","DOI":"10.1016\/j.tranon.2021.101174","article-title":"Global Colorectal Cancer Burden in 2020 and Projections to 2040","volume":"14","author":"Xi","year":"2021","journal-title":"Transl. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1101\/gad.348226.120","article-title":"Genetic and Biological Hallmarks of Colorectal Cancer","volume":"35","author":"Li","year":"2021","journal-title":"Genes Dev."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Ionescu, V.A., Gheorghe, G., Bacalbasa, N., Chiotoroiu, A.L., and Diaconu, C. (2023). Colorectal Cancer: From Risk Factors to Oncogenesis. Medicina, 59.","DOI":"10.20944\/preprints202308.1837.v1"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s10555-023-10158-3","article-title":"Colorectal Cancer: A Comprehensive Review of Carcinogenesis, Diagnosis, and Novel Strategies for Classified Treatments","volume":"43","author":"Abedizadeh","year":"2024","journal-title":"Cancer Metastasis Rev."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Underwood, P.W., Ruff, S.M., and Pawlik, T.M. (2024). Update on Targeted Therapy and Immunotherapy for Metastatic Colorectal Cancer. Cells, 13.","DOI":"10.3390\/cells13030245"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41588-024-01654-5","article-title":"Pathway Level Subtyping Identifies a Slow-Cycling Biological Phenotype Associated with Poor Clinical Outcomes in Colorectal Cancer","volume":"56","author":"Malla","year":"2024","journal-title":"Nat. Genet."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1136\/gutjnl-2016-313498","article-title":"Gut Microbiota Modulate T Cell Trafficking into Human Colorectal Cancer","volume":"67","author":"Cremonesi","year":"2018","journal-title":"Gut"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/s41577-021-00534-x","article-title":"The Inflammatory Pathogenesis of Colorectal Cancer","volume":"21","author":"Schmitt","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Borowczak, J., Szczerbowski, K., Maniewski, M., Kowalewski, A., Janiczek-Polewska, M., Szylberg, A., Marsza\u0142ek, A., and Szylberg, \u0141. (2022). The Role of Inflammatory Cytokines in the Pathogenesis of Colorectal Carcinoma\u2014Recent Findings and Review. Biomedicines, 10.","DOI":"10.3390\/biomedicines10071670"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000446486","article-title":"Radiotherapy for Colorectal Cancer: Current Standards and Future Perspectives","volume":"32","author":"Debus","year":"2016","journal-title":"Visc. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.4240\/wjgs.v15.i4.495","article-title":"Current and Emerging Therapeutic Approaches for Colorectal Cancer: A Comprehensive Review","volume":"15","author":"Kumar","year":"2023","journal-title":"World J. Gastrointest. Surg."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Dehelean, C.A., Marcovici, I., Soica, C., Mioc, M., Coricovac, D., Iurciuc, S., Cretu, O.M., and Pinzaru, I. (2021). Plant-Derived Anticancer Compounds as New Perspectives in Drug Discovery and Alternative Therapy. Molecules, 26.","DOI":"10.3390\/molecules26041109"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000443404","article-title":"Natural Products as a Vital Source for the Discovery of Cancer Chemotherapeutic and Chemopreventive Agents","volume":"25","author":"Cragg","year":"2016","journal-title":"Med. Princ. Pract."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"12234","DOI":"10.3748\/wjg.v21.i43.12234","article-title":"Irinotecan, a Key Chemotherapeutic Drug for Metastatic Colorectal Cancer","volume":"21","author":"Fujita","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1080\/10408398.2021.1976721","article-title":"Modulation of Inflammation by Phytochemicals to Enhance Efficacy and Reduce Toxicity of Cancer Chemotherapy","volume":"63","author":"Sahin","year":"2023","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-G\u00f3mez, L., and Uranga, J.A. (2024). Polyphenols in the Prevention and Treatment of Colorectal Cancer: A Systematic Review of Clinical Evidence. Nutrients, 16.","DOI":"10.3390\/nu16162735"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"9105261","DOI":"10.1155\/2018\/9105261","article-title":"Green Tea Catechins: Their Use in Treating and Preventing Infectious Diseases","volume":"2018","author":"Reygaert","year":"2018","journal-title":"BioMed Res. Int."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Farhan, M. (2022). Green Tea Catechins: Nature\u2019s Way of Preventing and Treating Cancer. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231810713"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Wang, Y.-Q., Li, Q.-S., Zheng, X.-Q., Lu, J.-L., and Liang, Y.-R. (2021). Antiviral Effects of Green Tea EGCG and Its Potential Application against COVID-19. Molecules, 26.","DOI":"10.3390\/molecules26133962"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s41702-020-0057-8","article-title":"Activity of Catechins and Their Applications","volume":"4","author":"Bae","year":"2020","journal-title":"Biomed. Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s10886-009-9681-x","article-title":"(\u00b1)-Catechin: Chemical Weapon, Antioxidant, or Stress Regulator?","volume":"35","author":"Chobot","year":"2009","journal-title":"J. Chem. Ecol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"8264","DOI":"10.1021\/acs.jafc.2c02150","article-title":"4\u2033-Sulfation Is the Major Metabolic Pathway of Epigallocatechin-3-Gallate in Humans: Characterization of Metabolites, Enzymatic Analysis, and Pharmacokinetic Profiling","volume":"70","author":"Hayashi","year":"2022","journal-title":"J. Agric. Food Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1093\/advances\/nmab085","article-title":"Contribution of Biotransformations Carried Out by the Microbiota, Drug-Metabolizing Enzymes, and Transport Proteins to the Biological Activities of Phytochemicals Found in the Diet","volume":"12","author":"Boronat","year":"2021","journal-title":"Adv. Nutr."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Capasso, L., De Masi, L., Sirignano, C., Maresca, V., Basile, A., Nebbioso, A., Rigano, D., and Bontempo, P. (2025). Epigallocatechin Gallate (EGCG): Pharmacological Properties, Biological Activities and Therapeutic Potential. Molecules, 30.","DOI":"10.3390\/molecules30030654"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Mirbabaei Ghafghazi, D., Kwan Sze, N.S., and Tsiani, E. (2026). Effects of Epigallocatechin Gallate Against Lung Cancer: Mechanisms of Action and Therapeutic Potential. Nutrients, 18.","DOI":"10.3390\/nu18030378"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Wei, R., Cortez Penso, N.E., Hackman, R.M., Wang, Y., and Mackenzie, G.G. (2019). Epigallocatechin-3-Gallate (EGCG) Suppresses Pancreatic Cancer Cell Growth, Invasion, and Migration Partly through the Inhibition of Akt Pathway and Epithelial\u2013Mesenchymal Transition: Enhanced Efficacy When Combined with Gemcitabine. Nutrients, 11.","DOI":"10.3390\/nu11081856"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Rodriguez Torres, S., Gresseau, L., Benhamida, M., Fernandez-Marrero, Y., and Annabi, B. (2023). Epigallocatechin-3-Gallate Prevents the Acquisition of a Cancer Stem Cell Phenotype in Ovarian Cancer Tumorspheres through the Inhibition of Src\/JAK\/STAT3 Signaling. Biomedicines, 11.","DOI":"10.3390\/biomedicines11041000"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"79557","DOI":"10.18632\/oncotarget.12836","article-title":"Epigallocatechin-3-Gallate(EGCG) Suppresses Melanoma Cell Growth and Metastasis by Targeting TRAF6 Activity","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Randisi, F., Perletti, G., Marras, E., and Gariboldi, M.B. (2025). Green Tea Components: In Vitro and In Vivo Evidence for Their Anticancer Potential in Colon Cancer. Cancers, 17.","DOI":"10.3390\/cancers17040623"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2174\/0109298673438731251212115733","article-title":"Potential Role and Mechanisms of Epigallocatechin-3-Gallate in Colorectal Cancer","volume":"33","author":"Bao","year":"2026","journal-title":"Curr. Med. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.abb.2010.03.017","article-title":"(\u2212)-Epigallocatechin-3-Gallate Inhibits Met Signaling, Proliferation, and Invasiveness in Human Colon Cancer Cells","volume":"501","author":"Larsen","year":"2010","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2147\/OTT.S40914","article-title":"Epigallocatechin Gallate Inhibits the Proliferation of Colorectal Cancer Cells by Regulating Notch Signaling","volume":"6","author":"Jin","year":"2013","journal-title":"OncoTargets Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3892\/or.2013.2925","article-title":"(\u2212)-Epigallocatechin-3-Gallate Suppresses Liver Metastasis of Human Colorectal Cancer","volume":"31","author":"Maruyama","year":"2014","journal-title":"Oncol. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Chen, Y., Wang, X.-Q., Zhang, Q., Zhu, J.-Y., Li, Y., Xie, C.-F., Li, X.-T., Wu, J.-S., Geng, S.-S., and Zhong, C.-Y. (2017). (\u2212)-Epigallocatechin-3-Gallate Inhibits Colorectal Cancer Stem Cells by Suppressing Wnt\/\u03b2-Catenin Pathway. Nutrients, 9.","DOI":"10.3390\/nu9060572"},{"key":"ref_36","first-page":"3480569","article-title":"Induction of Endoplasmic Reticulum Stress Pathway by Green Tea Epigallocatechin-3-Gallate (EGCG) in Colorectal Cancer Cells: Activation of PERK\/p-eIF2 \u03b1 \/ATF4 and IRE1 \u03b1","volume":"2019","author":"Shafie","year":"2019","journal-title":"BioMed Res. Int."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"7958041","DOI":"10.1155\/2020\/7958041","article-title":"Iron Chelation Properties of Green Tea Epigallocatechin-3-Gallate (EGCG) in Colorectal Cancer Cells: Analysis on Tfr\/Fth Regulations and Molecular Docking","volume":"2020","author":"Shafie","year":"2020","journal-title":"Evid.-Based Complement. Altern. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"115100","DOI":"10.1016\/j.taap.2020.115100","article-title":"Integrated Transcriptomic and Metabolomic Analyses to Characterize the Anti-Cancer Effects of (\u2212)-Epigallocatechin-3-Gallate in Human Colon Cancer Cells","volume":"401","author":"Zhang","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/gastro\/goaa072","article-title":"Tea Polyphenol EGCG Inhibited Colorectal-Cancer-Cell Proliferation and Migration via Downregulation of STAT3","volume":"9","author":"Luo","year":"2021","journal-title":"Gastroenterol. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"104570","DOI":"10.1016\/j.jff.2021.104570","article-title":"Targeting at Cancer Energy Metabolism and Lipid Droplet Formation as New Treatment Strategies for Epigallocatechin-3-Gallate (EGCG) in Colorectal Cancer Cells","volume":"83","author":"Wang","year":"2021","journal-title":"J. Funct. Foods"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3892\/ijo.2022.5309","article-title":"Epigallocatechin-3-gallate Hinders Metabolic Coupling to Suppress Colorectal Cancer Malignancy through Targeting Aerobic Glycolysis in Cancer-associated Fibroblasts","volume":"60","author":"Chen","year":"2022","journal-title":"Int. J. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/2211-5463.13391","article-title":"Epigallocatechin Gallate Triggers Apoptosis by Suppressing de Novo Lipogenesis in Colorectal Carcinoma Cells","volume":"12","author":"Khiewkamrop","year":"2022","journal-title":"FEBS Open Bio"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s11010-022-04550-w","article-title":"Epigallocatechin-3-Gallate Inhibits the Formation of Neutrophil Extracellular Traps and Suppresses the Migration and Invasion of Colon Cancer Cells by Regulating STAT3\/CXCL8 Pathway","volume":"478","author":"Zhang","year":"2023","journal-title":"Mol. Cell. Biochem."},{"key":"ref_44","first-page":"1407","article-title":"Improving the Anti-Tumor Effect of EGCG in Colorectal Cancer Cells by Blocking EGCG-Induced YAP Activation","volume":"13","author":"Wang","year":"2023","journal-title":"Am. J. Cancer Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1039\/D3FO03795A","article-title":"EGCG Oxidation-Derived Polymers Induce Apoptosis in Digestive Tract Cancer Cells via Regulating the Renin\u2013Angiotensin System","volume":"15","author":"Yang","year":"2024","journal-title":"Food Funct."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"150907","DOI":"10.1016\/j.bbrc.2024.150907","article-title":"Epigallocatechin-3-Gallate Induces Immunogenic Cell Death and Enhances Cancer Immunotherapy in Colorectal Cancer","volume":"736","author":"Lei","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.21873\/anticanres.17661","article-title":"Antitumor Effects of Epigallocatechin-3-Gallate on Colorectal Cancer: An In Vitro and In Vivo Study","volume":"45","author":"Suetsugu","year":"2025","journal-title":"Anticancer Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e17488","DOI":"10.1016\/j.heliyon.2023.e17488","article-title":"Advances in Drug Delivery Systems, Challenges and Future Directions","volume":"9","author":"Ezike","year":"2023","journal-title":"Heliyon"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"102068","DOI":"10.1016\/j.nano.2019.102068","article-title":"Enhanced Anti-Colon Cancer Efficacy of 5-Fluorouracil by Epigallocatechin-3- Gallate Co-Loaded in Wheat Germ Agglutinin-Conjugated Nanoparticles","volume":"21","author":"Wang","year":"2019","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12943-023-01790-2","article-title":"Metal-Enriched HSP90 Nanoinhibitor Overcomes Heat Resistance in Hyperthermic Intraperitoneal Chemotherapy Used for Peritoneal Metastases","volume":"22","author":"Wang","year":"2023","journal-title":"Mol. Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2217\/nnm-2023-0342","article-title":"pH-Sensitive Nanoparticles of Epigallocatechin-3-Gallate in Enhanced Colorectal Cancer Therapy","volume":"19","author":"Bhattacharya","year":"2024","journal-title":"Nanomedicine"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/10715762.2024.2360013","article-title":"Enhanced Anticancer Activity of (\u2013)-Epigallocatechin-3-Gallate (EGCG) Encapsulated NPs toward Colon Cancer Cell Lines","volume":"58","author":"Das","year":"2024","journal-title":"Free Radic. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/ptr.4707","article-title":"The Synergistic Apoptotic Interaction of Panaxadiol and Epigallocatechin Gallate in Human Colorectal Cancer Cells","volume":"27","author":"Du","year":"2013","journal-title":"Phyther. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jphs.2015.04.003","article-title":"EGCG Synergizes the Therapeutic Effect of Cisplatin and Oxaliplatin through Autophagic Pathway in Human Colorectal Cancer Cells","volume":"128","author":"Hu","year":"2015","journal-title":"J. Pharmacol. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/jgh.13069","article-title":"Epigallocatechin Gallate Hinders Human Hepatoma and Colon Cancer Sphere Formation","volume":"31","author":"Wubetu","year":"2016","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1021\/acs.jafc.8b06665","article-title":"(\u2212)-Epigallocatechin Gallate (EGCG) Enhances the Sensitivity of Colorectal Cancer Cells to 5-FU by Inhibiting GRP78\/NF-\u03baB\/miR-155-5p\/MDR1 Pathway","volume":"67","author":"La","year":"2019","journal-title":"J. Agric. Food Chem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1139\/cjpp-2020-0588","article-title":"Epigallocatechin-3-Gallate Inhibits Proliferation and Triggers Apoptosis in Colon Cancer via the Hedgehog\/Phosphoinositide 3-Kinase Pathways","volume":"99","author":"Ding","year":"2021","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e384","DOI":"10.1038\/oncsis.2017.84","article-title":"Combination Curcumin and (\u2212)-Epigallocatechin-3-Gallate Inhibits Colorectal Carcinoma Microenvironment-Induced Angiogenesis by JAK\/STAT3\/IL-8 Pathway","volume":"6","author":"Jin","year":"2017","journal-title":"Oncogenesis"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"6247","DOI":"10.21873\/anticanres.12980","article-title":"Epigallocatechin-3-Gallate Enhances Radiation Sensitivity in Colorectal Cancer Cells Through Nrf2 Activation and Autophagy","volume":"38","author":"Enkhbat","year":"2018","journal-title":"Anticancer Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"7913","DOI":"10.1111\/jcmm.16718","article-title":"EGCG Synergizes the Therapeutic Effect of Irinotecan through Enhanced DNA Damage in Human Colorectal Cancer Cells","volume":"25","author":"Wu","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"7099589","DOI":"10.1155\/2022\/7099589","article-title":"EGCG Enhances the Chemosensitivity of Colorectal Cancer to Irinotecan through GRP78-MediatedEndoplasmic Reticulum Stress","volume":"2022","author":"Wu","year":"2022","journal-title":"J. Oncol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"8128","DOI":"10.3748\/wjg.v23.i46.8128","article-title":"Structural Shift of Gut Microbiota during Chemo-Preventive Effects of Epigallocatechin Gallate on Colorectal Carcinogenesis in Mice","volume":"23","author":"Wang","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cbi.2010.03.036","article-title":"(\u2212)-Epigallocatechin Gallate Inhibits Growth and Activation of the VEGF\/VEGFR Axis in Human Colorectal Cancer Cells","volume":"185","author":"Shimizu","year":"2010","journal-title":"Chem.-Biol. Interact."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.3748\/wjg.v26.i17.2064","article-title":"Epigallocatechin Gallate Inhibits Dimethylhydrazine-Induced Colorectal Cancer in Rats","volume":"26","author":"Wang","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1177\/09603271211002884","article-title":"Amelioration of N,N\u2032-Dimethylhydrazine Induced Colon Toxicity by Epigallocatechin Gallate in Wistar Rats","volume":"40","author":"Afzal","year":"2021","journal-title":"Hum. Exp. Toxicol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.clnu.2017.01.014","article-title":"Green Tea Extracts for the Prevention of Metachronous Colorectal Polyps among Patients Who Underwent Endoscopic Removal of Colorectal Adenomas: A Randomized Clinical Trial","volume":"37","author":"Shin","year":"2018","journal-title":"Clin. Nutr."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1158\/1940-6207.CAPR-20-0598","article-title":"Randomized Phase II Trial of Polyphenon E versus Placebo in Patients at High Risk of Recurrent Colonic Neoplasia","volume":"14","author":"Sinicrope","year":"2021","journal-title":"Cancer Prev. Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"884","DOI":"10.14309\/ajg.0000000000001706","article-title":"Green Tea Extract to Prevent Colorectal Adenomas, Results of a Randomized, Placebo-Controlled Clinical Trial","volume":"117","author":"Seufferlein","year":"2022","journal-title":"Am. J. Gastroenterol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12935-019-0906-y","article-title":"Resveratrol Is a Promising Agent for Colorectal Cancer Prevention and Treatment: Focus on Molecular Mechanisms","volume":"19","author":"Honari","year":"2019","journal-title":"Cancer Cell Int."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Maugeri, A., Calderaro, A., Patan\u00e8, G.T., Navarra, M., Barreca, D., Cirmi, S., and Felice, M.R. (2023). Targets Involved in the Anti-Cancer Activity of Quercetin in Breast, Colorectal and Liver Neoplasms. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032952"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Asif Ali, M., Khan, N., Kaleem, N., Ahmad, W., Alharethi, S.H., Alharbi, B., Alhassan, H.H., Al-Enazi, M.M., Razis, A.F.A., and Modu, B. (2023). Anticancer Properties of Sulforaphane: Current Insights at the Molecular Level. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1168321"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"9262","DOI":"10.3748\/wjg.v21.i31.9262","article-title":"Role of Phytochemicals in Colorectal Cancer Prevention","volume":"21","author":"Li","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Termini, D., Den Hartogh, D.J., Jaglanian, A., and Tsiani, E. (2020). Curcumin against Prostate Cancer: Current Evidence. Biomolecules, 10.","DOI":"10.3390\/biom10111536"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Yousef, M., Vlachogiannis, I., and Tsiani, E. (2017). Effects of Resveratrol against Lung Cancer: In Vitro and In Vivo Studies. Nutrients, 9.","DOI":"10.3390\/nu9111231"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Nadile, M., Retsidou, M.I., Gioti, K., Beloukas, A., and Tsiani, E. (2022). Resveratrol against Cervical Cancer: Evidence from In Vitro and In Vivo Studies. Nutrients, 14.","DOI":"10.3390\/nu14245273"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/15\/2391\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T14:00:24Z","timestamp":1784901624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/15\/2391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":75,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["cancers18152391"],"URL":"https:\/\/doi.org\/10.3390\/cancers18152391","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]}}}